XWELL Return on Tangible Equity 2010-2024 | XWEL
Current and historical return on tangible equity values for XWELL (XWEL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| XWELL Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-06-30 | $-0.02B | $0.02B | -118.92% |
| 2024-03-31 | $-0.03B | $0.02B | -118.18% |
| 2023-12-31 | $-0.03B | $0.02B | -108.41% |
| 2023-09-30 | $-0.04B | $0.03B | -108.53% |
| 2023-06-30 | $-0.03B | $0.03B | -81.53% |
| 2023-03-31 | $-0.03B | $0.04B | -68.34% |
| 2022-12-31 | $-0.03B | $0.04B | -52.89% |
| 2022-09-30 | $-0.02B | $0.05B | -21.48% |
| 2022-06-30 | $-0.00B | $0.07B | -3.47% |
| 2022-03-31 | $0.00B | $0.08B | 1.09% |
| 2021-12-31 | $0.00B | $0.10B | 4.15% |
| 2021-09-30 | $-0.01B | $0.10B | -15.14% |
| 2021-06-30 | $-0.03B | $0.09B | -32.30% |
| 2021-03-31 | $-0.08B | $0.10B | -127.56% |
| 2020-12-31 | $-0.09B | $0.08B | -247.62% |
| 2020-09-30 | $-0.08B | $0.05B | -572.41% |
| 2020-06-30 | $-0.08B | $0.02B | -16400.00% |
| 2020-03-31 | $-0.03B | $-0.01B | 527.27% |
| 2019-12-31 | $-0.02B | $-0.01B | 840.00% |
| 2019-09-30 | $-0.02B | $-0.00B | -2800.00% |
| 2019-06-30 | $-0.02B | $0.00B | -633.33% |
| 2019-03-31 | $-0.02B | $0.00B | -340.00% |
| 2018-12-31 | $-0.04B | $0.00B | -524.14% |
| 2018-09-30 | $-0.04B | $0.01B | -420.00% |
| 2018-06-30 | $-0.04B | $0.01B | -352.00% |
| 2018-03-31 | $-0.05B | $0.01B | -341.82% |
| 2017-12-31 | $-0.03B | $0.02B | -190.16% |
| 2017-09-30 | $-0.02B | $0.02B | -115.79% |
| 2017-06-30 | $-0.02B | $0.01B | -111.39% |
| 2017-03-31 | $-0.03B | $0.02B | -119.54% |
| 2016-12-31 | $-0.02B | $0.03B | -107.87% |
| 2016-09-30 | $-0.00B | $0.02B | -20.51% |
| 2016-06-30 | $-0.01B | $0.02B | -72.13% |
| 2016-03-31 | $-0.01B | $0.02B | -81.82% |
| 2015-12-31 | $-0.01B | $0.02B | -141.18% |
| 2015-09-30 | $-0.10B | $0.00B | -1434.48% |
| 2015-06-30 | $-0.10B | $0.00B | -866.67% |
| 2015-03-31 | $-0.11B | $0.01B | -583.33% |
| 2014-12-31 | $-0.11B | $0.01B | -512.94% |
| 2014-09-30 | $-0.05B | $0.02B | -214.43% |
| 2014-06-30 | $-0.05B | $0.03B | -185.45% |
| 2014-03-31 | $-0.05B | $0.02B | -173.33% |
| 2013-12-31 | $-0.05B | $0.03B | -152.52% |
| 2013-09-30 | $-0.05B | $0.03B | -119.25% |
| 2013-06-30 | $-0.04B | $0.04B | -141.59% |
| 2013-03-31 | $-0.03B | $0.04B | -167.57% |
| 2012-12-31 | $-0.02B | $0.05B | -247.06% |
| 2012-09-30 | $-0.01B | $-0.01B | 200.00% |
| 2012-06-30 | $-0.00B | $-0.00B | 1600.00% |
| 2012-03-31 | $-0.00B | $0.00B | 800.00% |
| 2011-12-31 | $-0.00B | $0.00B | 300.00% |
| 2011-09-30 | $-0.01B | $-0.00B | 333.33% |
| 2011-06-30 | $-0.01B | $-0.00B | 933.33% |
| 2011-03-31 | $-0.01B | $-0.00B | -2000.00% |
| 2010-12-31 | $-0.01B | $0.00B | -1466.67% |
| 2010-06-30 | $-0.01B | $0.00B | -1066.67% |
| 2010-03-31 | $-0.00B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.009B | $0.030B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| Cencora (COR) | United States | $46.107B | 17.62 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |